Liz Beatty is co-founder and chief strategy officer at Inato, a french- and US-based global clinical trials marketplace that uses technology to disrupt traditional feasibility, enhance patient access, and foster site-sponsor collaboration. Inato flips the traditional feasibility model by empowering community sites to participate in the trials that are the best fit for them and their patients.
Liz is focused on advancing Inato’s corporate strategy, including efforts to promote diverse patient representation in clinical research as well as developing partnerships and driving growth globally. Previously, Liz headed digital clinical trials at Bristol-Myers Squibb, where she led digital innovation efforts across global clinical operations. She began her career as a clinical research coordinator at the Yale Multiple Sclerosis Research Center, bringing a unique site and sponsor perspective.